Compare · CLVT vs INFY
CLVT vs INFY
Side-by-side comparison of Clarivate Plc (CLVT) and Infosys Limited (INFY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLVT and INFY operate in EDP Services (Technology), so they compete in similar markets.
- INFY is the larger of the two at $49.20B, about 44.2x CLVT ($1.11B).
- CLVT has been more active in the news (13 items in the past 4 weeks vs 3 for INFY).
- Both have 25 recent analyst ratings on file.
- Company
- Clarivate Plc
- Infosys Limited
- Price
- -
- -
- Market cap
- $1.11B
- $49.20B
- 1M return
- -7.33%
- -
- 1Y return
- -50.00%
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 13
- 3
- Recent ratings
- 25
- 25
Clarivate Plc
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Infosys Limited
Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application development and management, independent validation, product engineering and management, infrastructure management, enterprise application management, and support and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Infosys Nia, an artificial intelligence platform; Infosys McCamish - an insurance platform; Wingspan, a customizable learning platform; Stater mortgage servicing platform; Panaya automation suite; and Skava, an e-commerce suite. The company serves clients in the financial services and insurance, life sciences and healthcare, manufacturing, retail, consumer packaged goods and logistics, hi-tech, communications, telecom OEM, media, energy, utilities, resources, services, and other industries. It has collaboration agreements with Rolls-Royce, BP plc, Newmont Corporation, RXR Realty, Majesco Limited, and Centre for Accessibility Australia. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.
Latest CLVT
- Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions
- Amendment: SEC Form 8-K/A filed by Clarivate Plc
- SEC Form 4 filed by Clarivate Plc
- SEC Form 8-K filed by Clarivate Plc
- Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
- Director Cornick Kenneth L. was granted 17,215 units of Ordinary Shares and covered exercise/tax liability with 3,444 units of Ordinary Shares, increasing direct ownership by 12% to 126,457 units (SEC Form 4)
- Director Snyder Andrew Miles was granted 30,688 units of Ordinary Shares and covered exercise/tax liability with 1,012 units of Ordinary Shares, increasing direct ownership by 10% to 322,592 units (SEC Form 4)
- Director Bomba Jane L Okun covered exercise/tax liability with 181 units of Ordinary Shares and was granted 17,215 units of Ordinary Shares, increasing direct ownership by 5% to 329,635 units (SEC Form 4)
- Clarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Latest INFY
- SEC Form 6-K filed by Infosys Limited
- Infosys and Columbia University Launch Strategic Collaboration Across Deep Research to Drive Innovation and Unlock Business Value
- Infosys and ABN Amro Extend Strategic Collaboration to Simplify IT Landscape and Accelerate AI-Driven Transformation
- Infosys downgraded by CLSA
- Infosys Collaborates with Knorr-Bremse to Accelerate AI-Enabled Enterprise Transformation
- Infosys and Metsä Group Expand Strategic Collaboration to Drive AI-led IT Transformation
- Investec Selects Infosys Finacle SaaS Platform on Microsoft Azure for Digital Banking Transformation
- SEC Form 6-K filed by Infosys Limited
- SEC Form 6-K filed by Infosys Limited
- Infosys downgraded by Analyst with a new price target